NATO AMEDP-7.5-1 PDF

Purpose

As stated in AMedP-7.5:¹²

The purpose of [the document AMedP-7.5] is to describe a methodology for estimating casualties uniquely occurring as a consequence of CBRN incidents near Allied forces, in support of the planning processes described in Allied Joint Publication 3.8 (AJP-3.8), Allied Joint Doctrine for NBC Defence,¹³ Allied Joint Publication 4.10 (AJP-4.10), Allied Joint Medical Support Doctrine,¹⁴ Allied Joint Medical Publication 1 (AJMedP-1), Allied Joint Medical Planning Doctrine,¹⁵ Allied Joint Medical Publication 7 (AJMedP-7), Allied Joint Medical Doctrine for Support to CBRN Defensive Operations,¹⁶ and Allied Medical Publication 7.6 (AMedP-7.6), Commander's Guide on Medical Support to Chemical, Biological, Radiological, and Nuclear (CBRN) Defensive Operations.¹⁷

The purpose of the methodology is to estimate the number, type, severity, and timing of CBRN casualties.

The purpose of CBRN casualty estimates is to assist planners, logisticians, and other staff officers in quantifying contingency requirements for medical force structure, specialty personnel, medical materiel, and patient transport or evacuation.

The purpose of this TRM is to describe the information presented in or used to develop the methodology described in AMedP-7.5. This document will:

• Describe the sources for, and justification of, the assumptions, limitations, and constraints and recommended values employed by the methodology;

• Identify, where appropriate, the sources for definitions and key terms used by the methodology, or else describe where and how new definitions and terms were derived;

• Document the derivation and/or supporting reasoning for the modeled symptomatology and the associated parameter values, lookup tables, equations, assumptions, limitations, constraints, and Injury Profiles for each agent of effect included in the methodology; and Provide a list of the references used in the development of this methodology and its human response models. The goal is to make the data underlying the components of the AMedP-7.5 methodology and the process through which it was developed as clear as possible and to enable analysts and modelers to understand and replicate these results and procedures.

¹² NATO, AMedP-7.5, 1-2–1-3.

¹³ North Atlantic Treaty Organization (NATO), AJP-3.8(A): Allied Joint Doctrine for CBRN Defence, STANAG 2451 (Brussels: NATO, 30 March 2012).

¹⁴ North Atlantic Treaty Organization (NATO), AJP-4.10(A): Allied Joint Medical Support Doctrine, STANAG 2228 (Brussels: NATO, 3 March 2006).

¹⁵ North Atlantic Treaty Organization (NATO), AJMedP-1: Allied Joint Medical Planning Doctrine, STANAG 2542 (Brussels: NATO, 3 November 2009).

¹⁶ North Atlantic Treaty Organization (NATO), AJMedP-7: Allied Joint Medical Doctrine for Support to CBRN Defensive Operations, STANAG 2596 (Brussels: NATO, 25 August 2015).

¹⁷ North Atlantic Treaty Organization (NATO), AMedP-7.6: Commander's Guide on Medical Support to Chemical, Biological, Radiological, and Nuclear (CBRN) Defensive Operations, STANAG 2873 (Brussels: NATO, study)